Literature DB >> 18177748

GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts.

Angela Ghatnekar1, Maria Trojanowska.   

Abstract

In this study we show that GATA-6 is a novel repressor of TN-C gene expression. We demonstrated that overexpression of GATA-6 in fibroblasts inhibited basal levels, as well as markedly decreased IL-4- and TGF-beta-induced TN-C mRNA and protein levels. A GATA-6 response element was mapped to position -467 to -460 of the TN-C promoter. In addition, we showed that GATA-6 binds this site both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177748      PMCID: PMC2295212          DOI: 10.1016/j.bbagrm.2007.11.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

Review 1.  The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression.

Authors:  J D Molkentin
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

2.  Transcriptional activation of BMP-4 and regulation of mammalian organogenesis by GATA-4 and -6.

Authors:  Georges Nemer; Mona Nemer
Journal:  Dev Biol       Date:  2003-02-01       Impact factor: 3.582

3.  Identification of a repressor in the first intron of the human alpha2(I) collagen gene (COL1A2).

Authors:  Taras T Antoniv; Shizuko Tanaka; Bayan Sudan; Sarah De Val; Ke Liu; Lu Wang; Dominic J Wells; George Bou-Gharios; Francesco Ramirez
Journal:  J Biol Chem       Date:  2005-08-08       Impact factor: 5.157

4.  Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.

Authors:  Sashidhar S Nakerakanti; Bagrat Kapanadze; Masaomi Yamasaki; Margaret Markiewicz; Maria Trojanowska
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

5.  Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation.

Authors:  W Huang; R Chiquet-Ehrismann; J V Moyano; A Garcia-Pardo; G Orend
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

6.  Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways.

Authors:  Kim S Midwood; Jean E Schwarzbauer
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

7.  Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction.

Authors:  K Imanaka-Yoshida; M Hiroe; T Nishikawa; S Ishiyama; T Shimojo; Y Ohta; T Sakakura; T Yoshida
Journal:  Lab Invest       Date:  2001-07       Impact factor: 5.662

Review 8.  The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling.

Authors:  F S Jones; P L Jones
Journal:  Dev Dyn       Date:  2000-06       Impact factor: 3.780

9.  GATA-4 binds to an upstream element of the human alpha2(I) collagen gene (COL1A2) and inhibits transcription in fibroblasts.

Authors:  Lu Wang; Shizuko Tanaka; Francesco Ramirez
Journal:  Matrix Biol       Date:  2005-08       Impact factor: 11.583

10.  Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding.

Authors:  Michael Eisbacher; Melissa L Holmes; Anthea Newton; Philip J Hogg; Levon M Khachigian; Merlin Crossley; Beng H Chong
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

View more
  10 in total

1.  Regulation of tenascin expression in bone.

Authors:  Jessica M Morgan; Alice Wong; Clare E Yellowley; Damian C Genetos
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 2.  Tenascins and the importance of adhesion modulation.

Authors:  Ruth Chiquet-Ehrismann; Richard P Tucker
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

3.  Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.

Authors:  Angela Ghatnekar; Izabela Chrobak; Charlie Reese; Lukasz Stawski; Francesca Seta; Elaine Wirrig; Jesus Paez-Cortez; Margaret Markiewicz; Yoshihide Asano; Russell Harley; Richard Silver; Carol Feghali-Bostwick; Maria Trojanowska
Journal:  Am J Pathol       Date:  2013-04-11       Impact factor: 4.307

Review 4.  Transcriptional regulation of tenascin genes.

Authors:  Francesca Chiovaro; Ruth Chiquet-Ehrismann; Matthias Chiquet
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

5.  OTX2 impedes self-renewal of porcine iPS cells through downregulation of NANOG expression.

Authors:  Ning Wang; Yaxian Wang; Youlong Xie; Huayan Wang
Journal:  Cell Death Discov       Date:  2016-12-05

6.  Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.

Authors:  Francesca Chiovaro; Enrico Martina; Alessia Bottos; Arnaud Scherberich; Nancy E Hynes; Ruth Chiquet-Ehrismann
Journal:  Int J Cancer       Date:  2015-04-29       Impact factor: 7.396

Review 7.  Role of tumor microenvironment in tumorigenesis.

Authors:  Maonan Wang; Jingzhou Zhao; Lishen Zhang; Fang Wei; Yu Lian; Yingfeng Wu; Zhaojian Gong; Shanshan Zhang; Jianda Zhou; Ke Cao; Xiayu Li; Wei Xiong; Guiyuan Li; Zhaoyang Zeng; Can Guo
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

8.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

9.  Mef2c regulates transcription of the extracellular matrix protein cartilage link protein 1 in the developing murine heart.

Authors:  Marie M Lockhart; Elaine E Wirrig; Aimee L Phelps; Angela V Ghatnekar; Jeremy L Barth; Russell A Norris; Andy Wessels
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

Review 10.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.